Evidence map›Paper›PMID 39499421›Full record

ArticleMolecular neurobiology2025

Global Co-regulatory Cross Talk Between m

Oliver Chukwuma Orji, Joseph Stones, Seema Rajani, Robert Markus, Merve Demirbugen Öz, Helen Miranda Knight

Abstract read
In one paragraph

Article in Molecular neurobiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. mInternational journal of molecular sciences · 2026
    Article
  7. Review
  8. Review
  9. The Role of mRNA Alternative Processing in Mammalian Neurodevelopment.International journal of molecular sciences · 2025
    Review
  10. Understanding the Molecular Basis of Miller-Dieker Syndrome.International journal of molecular sciences · 2025
    Review
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Oliver Chukwuma OrjiDivision of Cells, Organisms and Molecular Genetics, School of Life Sciences, University of Nottingham, Nottingham, NG7 2UH, UK.
Joseph StonesDivision of Cells, Organisms and Molecular Genetics, School of Life Sciences, University of Nottingham, Nottingham, NG7 2UH, UK.
Seema RajaniSchool of Life Sciences Imaging Facility, University of Nottingham, Nottingham, NG7 2UH, UK.
Robert MarkusSchool of Life Sciences Imaging Facility, University of Nottingham, Nottingham, NG7 2UH, UK.
Merve Demirbugen ÖzDepartment of Pharmaceutical Toxicology, Faculty of Pharmacy, Ankara University, Ankara, Turkey.
Helen Miranda KnightDivision of Cells, Organisms and Molecular Genetics, School of Life Sciences, University of Nottingham, Nottingham, NG7 2UH, UK. Helen.knight@nottingham.ac.uk.ORCID http://orcid.org/0000-0003-3267-9591

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

N6 adenosine and C5 cytosine modification of mRNAs, tRNAs and rRNAs are regulated by the behaviour of distinct sets of writer, reader and eraser effector proteins which are conventionally considered to function independently. Here, we provide evidence of global cross-regulatory and functional interaction between the m

Indexed as

5-MethylcytosineAdenosineBrainRNAAnimalsHumansMethylationProteomicsRNA Methylation5-MethylcytosineAdenosineN-methyladenosineRNA5-MethylcytosineBrain DiseaseCellular ResponseCo-RegulationN6-MethyladenosineRNA Modifications

Identifiers

PMID39499421
PMCPMC11880056

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.